BRII BIOSCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.27 HKD | -2.31% |
|
-5.22% | -44.30% |
| May. 15 | Brii Bio's Hepatitis B Drugs Get Breakthrough Therapy Designation in China | MT |
| Mar. 25 | Transcript : Brii Biosciences Limited, 2023 Earnings Call, Mar 25, 2024 |
Evolution of the average Target Price on Brii Biosciences Limited
Price target over the last 5 years
History of analyst recommendation changes
079afe4161c018a.LgBSNtsNzmkm3_gYNYd__z5F7bk43JBvW4EN3DS4EWU.HkchQK0-owZCqM11avRJzUsflckPneElE_tug3XWYR0eQyJknkasKFWwzA~588df4e1365a940c5711b5f8f4f3f948
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.177
CNY
Average target price
5.536
CNY
Spread / Average Target
+370.24%
High Price Target
5.536
CNY
Spread / Highest target
+370.24%
Low Price Target
5.536
CNY
Spread / Lowest Target
+370.24%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Brii Biosciences Limited
| UBS |
EPS Revisions
- Stock Market
- Equities
- 2137 Stock
- Consensus Brii Biosciences Limited
